Skip header and navigation

2 records – page 1 of 1.

Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness.

https://arctichealth.org/en/permalink/ahliterature91954
Source
Vaccine. 2008 Dec 9;26(52):6980-5
Publication Type
Article
Date
Dec-9-2008
Author
Velicko Inga
Müller Luise Ledet
Pebody Richard
Gergonne Bernadette
Aidyralieva Chinara
Kostiuchenko Nina
Spika John S
Author Affiliation
European Centre for Disease Prevention and Control, Solna, Sweden. inga.velicko@smi.se
Source
Vaccine. 2008 Dec 9;26(52):6980-5
Date
Dec-9-2008
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Case-Control Studies
Cohort Studies
Data Interpretation, Statistical
Disease Outbreaks
Humans
Immunization Programs
Measles - epidemiology - immunology
Measles Vaccine - immunology
Population Surveillance
Sample Size
Treatment Failure
Ukraine - epidemiology
Young Adult
Abstract
The WHO European Region has a measles elimination target for 2010. Between September 2005 and mid-June 2006, more than 50,000 measles cases were reported in Ukraine; many reportedly had received two doses of measles vaccine and over 60% were among persons 15-29 years old. To investigate vaccine effectiveness (VE), a case-control study was undertaken in Dnepropetrovsk region. VE for two doses of measles vaccine was 93.1%, providing insufficient population immunity for measles elimination. An additional dose of measles vaccine for these age-cohorts is required if Ukraine is to achieve measles elimination. Other republics of the former Soviet Union also need to consider a supplemental dose of measles vaccine for older age groups identified epidemiologically to be at increased risk for measles even though individuals may have already received two doses.
PubMed ID
18805455 View in PubMed
Less detail

Towards elimination: measles susceptibility in Australia and 17 European countries.

https://arctichealth.org/en/permalink/ahliterature86508
Source
Bull World Health Organ. 2008 Mar;86(3):197-204
Publication Type
Article
Date
Mar-2008
Author
Andrews Nick
Tischer Annedore
Siedler Annette
Pebody Richard G
Barbara Christopher
Cotter Suzanne
Duks Arnis
Gacheva Nina
Bohumir Kriz
Johansen Kari
Mossong Joel
Ory Fernando de
Prosenc Katarina
Sláciková Margareta
Theeten Heidi
Zarvou Marios
Pistol Adriana
Bartha Kalman
Cohen Dani
Backhouse Jo
Griskevicius Algirdas
Author Affiliation
Centre for Infections, Health Protection Agency, London, England. nick.andrews@hpa.org.uk
Source
Bull World Health Organ. 2008 Mar;86(3):197-204
Date
Mar-2008
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Australia - epidemiology
Blood Banks
Child
Child, Preschool
Europe - epidemiology
Humans
Immunization Programs - organization & administration
Measles - diagnosis - epidemiology - immunology - prevention & control
Measles Vaccine - immunology - therapeutic use
Questionnaires
Seroepidemiologic Studies
Vaccines, Attenuated
Abstract
OBJECTIVE: To evaluate age-specific measles susceptibility in Australia and 17 European countries. METHODS: As part of the European Sero-Epidemiology Network 2 (ESEN2), 18 countries collected large national serum banks between 1996 and 2004. These banks were tested for measles IgG and the results converted to a common unitage to enable valid intercountry comparisons. Historical vaccination and disease incidence data were also collected. Age-stratified population susceptibility levels were compared to WHO European Region targets for measles elimination of
PubMed ID
18368206 View in PubMed
Less detail